Everolimus-eluting stent versus bare metal stent in proximal left anterior descending ST-elevation myocardial infarction: Insights from the EXAMINATION trial

American Heart Journal

Volumn 166, Issue 1, 2013, Pages

  Gomez Lara, Josep ^a,b   Brugaletta, Salvatore ^c   Gomez Hospital, Joan Antoni ^a,b   Ferreiro, Jose Luis ^a,b   Roura, Gerard ^a,b   Romaguera, Rafael ^a,b   Martin Yuste, Victoria ^c   Masotti, Monica ^c   Iñiguez, Andrés ^d   Serra, Antonio ^e   Hernandez Antolin, Rosana ^f   Mainar, Vicente ^g   Valgimigli, Marco ^h   Tespili, Maurizio ⁱ   Den Heijer, Pieter ^j   Bethencourt, Armando ^k   Vazquez, Nicolás ^l   Serruys, Patrick ^m   Sabate, Manel ^c   Cequier, Angel ^a,b  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d HOSPITAL DO MEIXOEIRO   (Spain)

^e HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^f HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^g HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^h UNIVERSITY HOSPITAL OF FERRARA   (Italy)

ⁱ University Hospital Bolognini Seriate   (Italy)

^j AMPHIA HOSPITAL   (Netherlands)

^k HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^l HOSPITAL JUAN CANALEJO   (Spain)

^m ERASMUS MEDICAL CENTER   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EVEROLIMUS;

ADULT; ARTICLE; BARE METAL STENT; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; HEART DEATH; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

EID: 84879785942     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2013.04.012     Document Type: Article

References (19)

1. E.C. Keeley, J.A. Boura, and C.L. Grines Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials Lancet 361 9351 2003 13 20
2. S.S. Brar, M.B. Leon, and G.W. Stone Use of drug-eluting stents in acute myocardial infarction: a systematic review and meta-analysis J Am Coll Cardiol 53 18 2009 1677 1689
3. M.L. Antoni, K.H. Yiu, and J.Z. Atary Distribution of culprit lesions in patients with ST-segment elevation acute myocardial infarction treated with primary percutaneous coronary intervention Coron Artery Dis 22 8 2011 533 536
4. J. Karha, S.A. Murphy, and A.J. Kirtane Evaluation of the association of proximal coronary culprit artery lesion location with clinical outcomes in acute myocardial infarction Am J Cardiol 92 8 2003 913 918
5. M.S. Chen, J.M. John, and D.P. Chew Bare metal stent restenosis is not a benign clinical entity Am Heart J 151 6 2006 1260 1264
6. M. Busk, S.D. Kristensen, and K. Rasmussen Clinical reinfarction according to infarct location and reperfusion modality in patients with ST elevation myocardial infarction. A DANAMI-2 long-term follow-up substudy Cardiology 113 1 2009 72 80
7. M. Sabate, A. Cequier, and A. Iniguez Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial Lancet 380 9852 2012 1482 1490
8. M. Sabate, A. Cequier, and A. Iniguez Rationale and design of the EXAMINATION trial: a randomised comparison between everolimus-eluting stents and cobalt-chromium bare-metal stents in ST-elevation myocardial infarction EuroIntervention 7 8 2011 977 984
9. F.G. Kushner, M. Hand, and S.C. Smith Jr. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 54 23 2009 2205 2241
10. P.G. Steg, S.K. James, and D. Atar ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC) Eur Heart J 2012
11. S. Ramcharitar, M. Hochadel, and A.L. Gaster An insight into the current use of drug eluting stents in acute and elective percutaneous coronary interventions in Europe. A report on the EuroPCI Survey EuroIntervention 3 4 2008 429 441
12. S.K. James, U. Stenestrand, and J. Lindback Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden N Engl J Med 360 19 2009 1933 1945
13. P.G. Steg, K.A. Fox, and K.A. Eagle Mortality following placement of drug-eluting and bare-metal stents for ST-segment elevation acute myocardial infarction in the Global Registry of Acute Coronary Events Eur Heart J 30 3 2009 321 329
14. N.J. Verouden, J.D. Haeck, and W.J. Kuijt Clinical and angiographic predictors of ST-segment recovery after primary percutaneous coronary intervention Am J Cardiol 105 12 2010 1692 1697
15. G.W. Stone, H. Parise, and B. Witzenbichler Selection criteria for drug-eluting versus bare-metal stents and the impact of routine angiographic follow-up: 2-year insights from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial J Am Coll Cardiol 56 19 2010 1597 1604
16. I.M. Shugman, L. Hee, and C.J. Mussap Bare-metal stenting of large coronary arteries in ST-elevation myocardial infarction is associated with low rates of target vessel revascularization Am Heart J 165 4 2013 591 599
17. E. Kedhi, M. Gomes, and K.S. Joesoef Everolimus-eluting stents and paclitaxel-eluting stents in patients presenting with myocardial infarction: insights from the two-year results of the COMPARE prospective randomised controlled trial EuroIntervention 7 12 2012 1376 1385
18. S.H. Hofma, J. Brouwer, and M.A. Velders Second-Generation Everolimus-Eluting Stents Versus First-Generation Sirolimus-Eluting Stents in Acute Myocardial Infarction: 1-Year Results of the Randomized XAMI (XienceV Stent vs. Cypher Stent in Primary PCI for Acute Myocardial Infarction) Trial J Am Coll Cardiol 60 5 2012 381 387
19. L. Raber, H. Kelbaek, and M. Ostoijc Effect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction: the COMFORTABLE AMI randomized trial JAMA 308 8 2012 777 787